X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-04 | FATE | Dulac Edward J III | CFO | S - Sale | $7.77 | -2,447 | 101,479 | -2% | -$19,013 | ||||||
2024-01-29 | FATE | Dulac Edward J III | CFO | S - Sale | $5.00 | -1,849 | 103,926 | -2% | -$9,245 | ||||||
2024-01-09 | FATE | Tahl Cindy | GC, Secretary | S - Sale | $4.37 | -10,874 | 142,361 | -7% | -$47,519 | ||||||
2024-01-09 | FATE | Valamehr Bahram | Chief R, D Officer | S - Sale | $4.38 | -11,271 | 158,069 | -7% | -$49,367 | ||||||
2024-01-09 | FATE | Wolchko J Scott | Pres, CEO | S - Sale | $4.37 | -14,391 | 371,248 | -4% | -$62,889 | ||||||
2024-01-09 | FATE | Dulac Edward J III | CFO | S - Sale | $4.37 | -7,028 | 105,775 | -6% | -$30,712 | ||||||
2024-01-02 | FATE | Dulac Edward J III | CFO | S - Sale | $3.66 | -5,182 | 112,803 | -4% | -$18,966 | ||||||
2023-12-26 | FATE | Redmile Group, LLC | Dir, 10% | P - Purchase | $3.72 | +44,630 | 13,180,388 | 0% | +$166,024 | ||||||
2023-12-18 | FATE | Dulac Edward J III | CFO | S - Sale | $3.50 | -1,585 | 117,985 | -1% | -$5,548 | ||||||
2023-11-09 | FATE | Tahl Cindy | GC, Secretary | S - Sale | $2.40 | -24,363 | 153,235 | -14% | -$58,471 | ||||||
2023-08-18 | FATE | Dulac Edward J III | CFO | S - Sale | $2.80 | -4,718 | 119,570 | -4% | -$13,210 | ||||||
2023-08-04 | FATE | Xu Yuan | Dir | S - Sale | $3.71 | -632 | 9,302 | -6% | -$2,345 | ||||||
2023-07-05 | FATE | Powl Brian T. | Chief Commercial Officer | S - Sale | $4.87 | -3,854 | 41,146 | -9% | -$18,769 | ||||||
2023-07-05 | FATE | Dulac Edward J III | CFO | S - Sale | $4.83 | -5,182 | 124,288 | -4% | -$25,029 | ||||||
2023-06-14 | FATE | Xu Yuan | Dir | S - Sale | $5.58 | -3,460 | 9,934 | -26% | -$19,307 | ||||||
| M | 2023-04-20 | FATE | Redmile Group, LLC | Dir, 10% | P - Purchase | $6.17 | +276,639 | 13,135,758 | +2% | +$1,705,829 | |||||
2023-04-18 | FATE | Chu Yu-Waye | Chief Medical Officer | S - Sale | $6.57 | -2,532 | 140,676 | -2% | -$16,648 | ||||||
| D | 2023-04-14 | FATE | Redmile Group, LLC | Dir, 10% | S - Sale+OE | $5.84 | -302,339 | 12,859,119 | -2% | -$1,765,660 | |||||
| D | 2023-04-14 | FATE | Redmile Group, LLC | Dir, 10% | P - Purchase | $6.00 | +25,700 | 12,859,119 | 0% | +$154,200 | |||||
| M | 2023-01-11 | FATE | Mendlein John | Dir | P - Purchase | $5.60 | +124,679 | 282,770 | +79% | +$698,138 | |||||
2023-01-10 | FATE | Wolchko J Scott | Pres, CEO | S - Sale | $5.24 | -45,907 | 385,639 | -11% | -$240,553 | ||||||
2023-01-10 | FATE | Valamehr Bahram | Chief R, D Officer | S - Sale | $5.24 | -10,917 | 168,917 | -6% | -$57,205 | ||||||
2023-01-10 | FATE | Tahl Cindy | GC, Secretary | S - Sale | $5.24 | -11,553 | 177,598 | -6% | -$60,538 | ||||||
2023-01-10 | FATE | Plavsic Mark | Chief Technical Officer | S - Sale | $5.24 | -3,418 | 123,705 | -3% | -$17,910 | ||||||
2023-01-10 | FATE | Dulac Edward J III | CFO | S - Sale | $5.24 | -7,331 | 129,470 | -5% | -$38,414 | ||||||
2023-01-10 | FATE | Chu Yu-Waye | Chief Medical Officer | S - Sale | $5.24 | -7,825 | 143,208 | -5% | -$41,003 | ||||||
2022-08-18 | FATE | Dulac Edward J III | CFO | S - Sale | $29.81 | -5,135 | 136,801 | -4% | -$153,051 | ||||||
| DM | 2022-07-21 | FATE | Wolchko J Scott | Pres, CEO | S - Sale+OE | $32.74 | -36,246 | 431,546 | -8% | -$1,186,717 | |||||
| D | 2022-07-07 | FATE | Valamehr Bahram | Chief R, D Officer | S - Sale+OE | $30.23 | -17,158 | 179,834 | -9% | -$518,686 | |||||
| D | 2022-07-06 | FATE | Valamehr Bahram | Chief R, D Officer | S - Sale+OE | $30.07 | -7,842 | 179,834 | -4% | -$235,809 | |||||
2022-07-05 | FATE | Plavsic Mark | Chief Technical Officer | S - Sale | $24.61 | -3,719 | 127,123 | -3% | -$91,525 | ||||||
2022-06-07 | FATE | Agarwal Shefali | Dir | S - Sale | $21.89 | -841 | 1,840 | -31% | -$18,409 | ||||||
| A | 2022-06-03 | FATE | Agarwal Shefali | Dir | S - Sale | $0.00 | -0 | 2,681 | 0% | -$0 | |||||
2022-06-03 | FATE | Mendlein John | Dir | S - Sale | $22.79 | -1,364 | 158,091 | -1% | -$31,086 | ||||||
2022-06-03 | FATE | Jooss Karin | Dir | S - Sale | $22.82 | -1,483 | 1,198 | -55% | -$33,842 | ||||||
2022-06-03 | FATE | Hershberg Robert | Dir | S - Sale | $22.75 | -672 | 2,009 | -25% | -$15,288 | ||||||
2022-06-03 | FATE | Coughlin Timothy | Dir | S - Sale | $22.81 | -1,439 | 57,632 | -2% | -$32,824 | ||||||
2022-06-03 | FATE | Agarwal Shefali | Dir | S - Sale | $22.80 | -807 | 1,874 | -30% | -$18,400 | ||||||
| D | 2022-06-01 | FATE | Tahl Cindy | GC, Secretary | S - Sale+OE | $22.96 | -25,000 | 189,151 | -12% | -$574,000 | |||||
| DM | 2022-04-21 | FATE | Wolchko J Scott | Pres, CEO | S - Sale+OE | $34.89 | -40,000 | 431,546 | -8% | -$1,395,792 | |||||
2022-04-19 | FATE | Chu Yu-Waye | Chief Medical Officer | S - Sale | $35.37 | -4,062 | 151,033 | -3% | -$143,673 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |